Interaction of inflammation and portal hypertension in cirrhosis progression
- 29 September 2025
- journal article
- review article
- Published by Springer Nature in Nature Reviews Gastroenterology & Hepatology
- Vol. 22 (12) , 846-865
Abstract
Decompensated cirrhosis describes an advanced clinical stage with clinical complications, such as ascites, variceal bleeding or hepatic encephalopathy, associated with considerable mortality. Portal hypertension is the main risk factor for developing decompensation in patients with compensated cirrhosis, whereas systemic inflammation is the key driving force for organ failure, that is, for acute-on-chronic liver failure in later stages of cirrhosis. As portal hypertension and systemic inflammation coexist in patients with cirrhosis, an improved understanding of their interaction and dynamic role in distinct stages of cirrhosis is an important step forward towards the development of urgently needed therapeutic interventions. Based on emerging evidence from clinical and translational studies, a novel concept of different predominant pathomechanisms of decompensated cirrhosis is presented, which includes portal hypertension-predominant, systemic inflammmation-predominant and mixed portal hypertension-systemic inflammation phenotypes. A comprehensive set of biomarkers and surrogates of portal hypertension and systemic inflammation might assist clinicians in identifying a predominance of one over the other cirrhosis phenotype. As survival rates of patients with decompensated cirrhosis have remained detrimental without liver transplantation over the past decades, future studies should build on this knowledge to develop effective portal hypertension and systemic inflammation-directed therapies for this underserved population.Keywords
This publication has 234 references indexed in Scilit:
- Oral Bile Acids Reduce Bacterial Overgrowth, Bacterial Translocation, and Endotoxemia in Cirrhotic RatsHepatology, 2003
- Liver transplantation improves hepatic myelopathy: Evidence by three casesGastroenterology, 2003
- Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangementHepatology, 2003
- Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the ratGastroenterology, 2002
- Role of Nitric Oxide in Hepatopulmonary Syndrome in Cirrhotic RatsAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascitesHepatology, 2000
- Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortalityHepatology, 1998
- The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndromeGastroenterology, 1997
- Vasopressin release and water metabolism in patients with cirrhosisJournal of Hepatology, 1994
- Bacterial translocation in acute and chronic portal hypertensionHepatology, 1993